Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Cytotherapy. 2023 Jun 16;25(9):977–985. doi: 10.1016/j.jcyt.2023.05.012

Figure 3. Linearity and maximally selected log-rank statistics analyses on the correlation between B cell immune reconstitution and non-relapse mortality.

Figure 3.

(a) Martingale residual plot demonstrating excess risk of non-relapse mortality by highest achieved absolute B cell count in the first 100 days after allo-HCT. The non-linear trajectory of the curve indicates there is no linear correlation between B cell count and non-relapse mortality, (b) distribution of the B cell values, (c) maximally selected log-rank statistics determining an absolute B cell count of 25 as the cut off for NRM, (d) cumulative incidence curves of NRM comparing patients who achieved a maximum B cell count > 25 cells/μl (dotted line) and those who did not (solid line), confirming a significant difference between the two groups. P value depicts significance of B cell IR > 25 cells/μl as predictor in univariable competing risk analyses by the Fine-Gray method.